February 28, 2024
We're thrilled to announce that Menten AI has joined the Ginkgo Technology Network, aiming to empower scientists and industry leaders in advancing their research endeavors. Through this collaboration, Menten AI will integrate its cutting-edge AI capabilities into Ginkgo's network, offering customers enhanced solutions for designing cyclic peptides and driving successful research and development outcomes in the pharmaceutical market.
At Ginkgo, the belief is that customers developing groundbreaking, often life-saving products, deserve the best tools available to ensure success. We're proud that Ginkgo recognizes Menten AI's innovative solutions, reflecting our dedication to supporting partners in achieving optimal outcomes across diverse projects.
Menten AI is currently developing the world's most advanced physics-based generative AI platform for cyclic peptide design, enabling us to assist partners in developing cyclic peptides for various applications, including permeable peptides, PPI binders, molecular glues, conjugated peptides, and inhibitors. Collaborating with esteemed service providers and industry leaders like Ginkgo enables us to expand our reach and assist more partners in achieving their objectives.
Ginkgo Bioworks is a biotechnology company pioneering the application of biology as a programming platform to enable the growth of sustainable industries. Their mission is to make biology easier to engineer, addressing global challenges in health, energy, and more.
